Cargando…

Pooled analysis of mid-regional pro-adrenomedullin values in COVID-19 patients with critical illness

Detalles Bibliográficos
Autores principales:	Lippi, Giuseppe, Henry, Brandon Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	CE-Research Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104917/ https://www.ncbi.nlm.nih.gov/pubmed/33963517 http://dx.doi.org/10.1007/s11739-021-02756-2

Ejemplares similares

Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis
por: Henry, Brandon Michael, et al.
Publicado: (2020)

The burden of thrombotic complications in critically ill patients with COVID-19: charting the uncharted
por: Landi, Antonio, et al.
Publicado: (2020)

Two different patterns of lymphocyte alterations in critically ill COVID-19 patients
por: Lafarge, Antoine, et al.
Publicado: (2021)

Role of doctors in epidemics: historical perspectives and implications for COVID-19
por: Lippi, Donatella, et al.
Publicado: (2020)

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study
por: Oblitas, Crhistian-Mario, et al.
Publicado: (2021)

The value of plasma pro-enkephalin and adrenomedullin for the prediction of sepsis-associated acute kidney injury in critically ill patients
por: Liu, Ruijin, et al.
Publicado: (2020)

COVID-19 vaccines and thrombosis
por: Famularo, Giuseppe
Publicado: (2021)

Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study
por: Vigué, Bernard, et al.
Publicado: (2016)

COVID-19: in the uncertainty, do not try this at home
por: Lupia, Tommaso, et al.
Publicado: (2020)

The Association of Mid-Regional Pro-Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide with Mortality in an Incident Dialysis Cohort
por: Gouya, Ghazaleh, et al.
Publicado: (2011)

Prognostic value of pro-atrial natriuretic peptide, pro-adrenomedullin, and pro-endothelin-1 in critically ill patients
por: Bloos, F, et al.
Publicado: (2006)

Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS
por: de Montmollin, Etienne, et al.
Publicado: (2022)

Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study
por: Christ-Crain, Mirjam, et al.
Publicado: (2005)

Ethics in the age of COVID-19
por: Arora, Ananya, et al.
Publicado: (2020)

COVID-19: thoughts at sunrise
por: Gasbarrini, Giovanni
Publicado: (2020)

Camostat mesilate therapy for COVID-19
por: Uno, Yoshiharu
Publicado: (2020)

COVID-19 and elderly: beyond the respiratory drama
por: Sciacqua, Angela, et al.
Publicado: (2020)

COVID-19: a clinical and organizational crisis
por: Russo, Emanuele, et al.
Publicado: (2020)

Should the search for COVID-19 become part of the work-up of incidental thromboembolism? A near-missed COVID-19 diagnosis
por: Franceschini, Marta, et al.
Publicado: (2020)

Central neurological complications and potential neuropathogenesis of COVID-19
por: Wang, Jianing, et al.
Publicado: (2020)

COVID-19 and asplenia: a Janus-faced issue
por: Lenti, Marco Vincenzo, et al.
Publicado: (2021)

Telemedicine in the acute care setting during the COVID-19 pandemic
por: Lin, Ziwei, et al.
Publicado: (2020)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

High-dose steroids for the treatment of severe COVID-19: comment
por: Tanaka, Shuichi, et al.
Publicado: (2021)

Communication and relationship at time of COVID-19: a possible heritage
por: Vegni, Elena, et al.
Publicado: (2022)

Delirium in COVID‑19 pneumonia: looking inside the geriatric unit
por: Vargas, Nicolas, et al.
Publicado: (2022)

Fibrosis‑4 (FIB‑4) index and mortality in COVID‑19 patients admitted to the emergency department: a new interesting predictive index for patients with COVID-19 disease?
por: Ruggeri, Paolo, et al.
Publicado: (2022)

Triage decision-making at the time of COVID-19 infection: the Piacenza strategy
por: Erika, Poggiali, et al.
Publicado: (2020)

Delirium in COVID‑19 pneumonia: looking inside the geriatric unit—reply
por: Callea, Antonio, et al.
Publicado: (2022)

Lung ultrasound presentation of covid-19 patients: phenotypes and correlations—comment
por: Nekludova, Galina, et al.
Publicado: (2021)

Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine
por: Carli, Giuseppe, et al.
Publicado: (2021)

Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010)

Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment
por: Ponzetto, Antonio, et al.
Publicado: (2020)

When internal and emergency medicine speak to each other: organization in the time of COVID
por: Cogliati, Chiara, et al.
Publicado: (2020)

COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder
por: Tamburin, Stefano, et al.
Publicado: (2021)

Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?
por: Pasin, Federico, et al.
Publicado: (2021)

Oxygen–ozone treatment and COVID-19: antioxidants targeting endothelia lead the scenery
por: Varesi, Angelica, et al.
Publicado: (2021)

Incidence and outcome of delirium during helmet CPAP treatment in COVID-19 patients
por: Samartin, Federica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_82nthfcknc53ihf61atq7p5fkv